Teresa Blanco-Mortera

Huddinge, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Real-world investigation of germline predisposition to myelodysplastic syndromes.

Real-world investigation of germline predisposition to myelodysplastic syndromes.

Journal: Blood advances
Published: February 04, 2026

Stable clonal contribution of lineage-restricted stem cells to human hematopoiesis.

Stable clonal contribution of lineage-restricted stem cells to human hematopoiesis.

Journal: Nature genetics
Published: June 05, 2025

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

Journal: Leukemia
Published: April 14, 2025

Germline UBA1 Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic Syndrome.

Germline UBA1 Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic Syndrome.

Journal: Annals of internal medicine
Published: January 20, 2025

Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes.

Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes.

Journal: Journal of internal medicine
Published: April 24, 2024

Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells.

Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells.

Journal: Blood neoplasia
Published: February 12, 2024

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.

Journal: Blood
Published: October 19, 2023

Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.

Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.

Journal: Cancer research
Published: October 03, 2023

Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts.

Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 20, 2023

The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS.

The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS.

Journal: Blood advances
Published: April 14, 2022

Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs.

Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs.

Journal: Blood advances
Published: October 13, 2021

Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome.

Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome.

Journal: Nature cell biology
Published: December 07, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026